Risk score for individual transplant procedures as established by the European Group for Blood and Marrow Transplantation.32
| Feature . | Score . |
|---|---|
| A. Donor type | |
| HLA-identical sibling | 0 |
| Unrelated/non-identical | 1 |
| B. Stage of disease: | |
| Chronic phase | 0 |
| Accelerated phase | 1 |
| Blast crisis | 2 |
| C. Age: | |
| < 20 years | 0 |
| 20-40 years | 1 |
| >40 years | 2 |
| D. Donor/recipient sex combination: | |
| Other | 0 |
| Female donor for male recipient | 1 |
| E. Interval from diagnosis to transplant: | |
| < 12 months | 0 |
| > 12 months | 1 |
| Feature . | Score . |
|---|---|
| A. Donor type | |
| HLA-identical sibling | 0 |
| Unrelated/non-identical | 1 |
| B. Stage of disease: | |
| Chronic phase | 0 |
| Accelerated phase | 1 |
| Blast crisis | 2 |
| C. Age: | |
| < 20 years | 0 |
| 20-40 years | 1 |
| >40 years | 2 |
| D. Donor/recipient sex combination: | |
| Other | 0 |
| Female donor for male recipient | 1 |
| E. Interval from diagnosis to transplant: | |
| < 12 months | 0 |
| > 12 months | 1 |